Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results
Cancer
 
Search Results



Your search returned 1870 record(s).

Page 172 of 187  |  Previous Page   |  Next Page

Cancer Type:   Sort By:

This Search was Made Possible by:


  Survival: Patients: Toxicity: Treatment: Hospital: Country: Date:
1711 2.1 months Inoperable hepatocellular (liver) carcinoma Hormone
Singapore General Hospital Singapore 11/2002
Treatment Details: Patients: This study involved 324 patients with inoperable hepatocellular (liver) carcinoma. Patients were divided into three groups: two groups of patients (74 and 120 patients) who were
 
1712 2.0 months Metastatic rcc 4 Gene Therapy
Immunotherapy
City of Hope National Medical Center United States 5/2007
Treatment Details: Patients: This phase II study involved 23 patients with advanced metastatic renal cancer. Fourteen were men and 9 were women. The median age was 60 years, ranging from 40 to 70. Trea
 
1713 N/R Metastatic prostate cancer 3 Biologic therapy
Massachusetts General Hospital United States 6/2006
Treatment Details: Patients: This phase II study involved 44 men with metastatic prostate cancer. The men were divided into two groups of 22 patients, group 1 and group 2. The mean age of group 1 was 75.6 y
 
1714 N/R Metastatic rcc 4 Gene Therapy
London Health Sciences Centre Canada 3/2006
Treatment Details: Patients: This Phase II trial involved a total of 17 patients with metastatic renal cell carcinoma. There were 11 men and 6 women. The median age was 60. Treatment: The treatment consis
 
1715 N/R Rectal cancer 5 Chemotherapy
Radiation
University of Erlangen Germany 1/2007
Treatment Details: Patients: This phase II trial involved 104 people with rectal adenocarcinoma. The median age was 61, ranging from 39 to 77 years. Seventy-three percent of the patients were men. Trea
 
1716 N/R Advanced recurrent ovarian 4 Chemotherapy
Cleveland Clinic Foundation United States 12/2005
Treatment Details: Patients: This Phase I/II study involved 17 women with relapsed ovarian or peritoneal cancer. None of the patients had prior radiotherapy, and all patients had at least one chemotherapy tre
 
1717 N/R Advanced or recurrent colorectal cancer 2 Immunotherapy
Sapporo Medical University School of Medicine Japan 6/2004
Treatment Details: Patients: This Phase I study involved 15 patients with advanced or recurrent colorectal cancer. Treatment: The treatment (immunotherapy) consisted of a survivin-2B peptide vaccination.
 
1718 N/R Advanced or recurrent colorectal cancer 2 Immunotherapy
Sapporo Medical University School of Medicine Japan 6/2004
Treatment Details: Patients: This Phase I study involved 15 patients with advanced or recurrent colorectal cancer. Treatment: The treatment (immunotherapy) consisted of a survivin-2B peptide vaccination.
 
1719 N/R Advanced colorectal cancer 4 Biologic therapy
Chemotherapy
Royal Free and University College Medical School United Kingdom 8/2002
Treatment Details: Patients: This Phase I study involved 27 patients of which 25 had advanced colorectal cancer. Treatment: The treatment consisted of antibody-directed enzyme prodrug therapy (ADEPT) in whi
 
1720 N/R Locally advanced or metastatic colorectal cancer 3 Biologic therapy
Ottawa Regional Cancer Centre Canada 7/2002
Treatment Details: Patients: This Phase II study involved 37 treated patients with locally advanced or metastatic colorectal cancer. Twenty-eight patients had metastasis to the liver. Nineteen patients were
 
Page 172 of 187  | Previous Page  | Next Page